Effect of topical administration of 2% dorzlamide hydrochloride or 2% dorzlamide hydrochloride-0.5% timolol maleate on intraocular pressure in clinically normal horses

American Journal of Veterinary Research

Volumn 62, Issue 5, 2001, Pages 709-713

  Willis, A Michelle ^a,b   Robbin, Terah E ^a   Hoshaw Woodard, Stacy ^a   Wilkie, David A ^a   Schmall, Michael L ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b Rowley Memorial Animal Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DORZOLAMIDE; DORZOLAMIDE PLUS TIMOLOL; TIMOLOL MALEATE;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MIXTURE; HORSE; INTRAOCULAR PRESSURE; NONHUMAN; REGRESSION ANALYSIS;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 0035037704     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2001.62.709     Document Type: Article

References (41)

1. Miller TR, Brooks DE, Gelatt KN, et al. Equine glaucoma: clinical findings and response to treatment in 14 horses. Vet Comp Ophthalmol 1945;5:170-182.
2. Smith PJ, Samuelson DA, Brooks DE, et al. Unconventional aqueous humor outflow of microspheres perfused into the equine eye. Am J Vet Res 1986;47:2445-2453.
3. Samuelson D, Smith P, Brooks D. Morphologic features of the aqueous humor drainage pathways in horses. Am J Vet Res 1989; 50:720-727.
4. Kass MA. Topical carbonic anhydrase inhibitors. Am J Ophthalmol 1989;107:280-282.
5. van der Woerdt A, Gilger BC, Wilkie DA, et al. Normal variation in, and effect of 2% pilocarpine on, intraocular pressure and pupil size in female horses. Am J Vet Res 1998;59:1454-1462.
6. Martin CL, Wyman M. Primary glaucoma in the dog. Vet Clin North Am Small Anim Pract 1978;8:257-287.
7. Davidson MG. Equine ophthalmology. In: Gelatt KN, ed. Veterinary ophthalmology. 2nd ed. Philadelphia: Lea & Febiger, 1991;598-599.
8. Herring IP, Pickett JP, Champagne ES, et al. Effect of topical 1% atropine sulphate on intraocular pressure in normal horses. Vet Ophthalmol 2000;3:139-143.
9. Mughannam AJ, Buyukmihci NC, Kass PH. Effect of topical atropine in intraocular pressure and pupil diameter in the normal horse eye. Vet Ophthalmol 1999;2:213-215.
10. van der Woerdt A, Gilger BC, Wilkie DA, et al. Effect of single- and multiple-dose 0.5% timolol maleate on intraocular pressure and pupil size in female horses. Vet Ophthalmol 2000;3:165-168.
11. Havener WH. Autonomic drugs. In: Havener WH, ed. Ocular pharmacology St Louis: CV Mosby Co, 1986;261-417.
12. Larsson L, Alm A. Aqueous humor flow in human eyes treated with dorzolamide and different doses of acetazolamide. Arch Ophthalmol 1998;116:19-224.
13. Regnier A, Toutain PL. Ocular pharmacology and therapeutic modalities. In: Gelatt KN, ed. Veterinary ophthalmology. 2nd ed. Philadelphia: Lea & Febiger, 1991;178-174.
14. Everitt DE, Avorn J. Systemic effects of medications used to treat glaucoma. Ann Intern Med 1990;112:120-125.
15. Wayman L, Larsson L, Muns T, et al. Comparison of dorzolamide and timolol as suppressors of aqueous humor flow in humans. Arch Opthalmol 1997;115:1368-1371.
16. van der Woerdt A, Gilger BC, Wilkie DA, et al. Effect of auriculopalpebral nerve block and intravenous administration of xylazine on intraocular pressure and corneal thickness in horses. Am J Vet Res 1995;56:155-158.
17. Cohen CM, Reinke DA. Equine tonometry. J Am Vet Med Assoc 1970;156:1884-1887.
18. McClure JR, Gelatt KN, Gum GG, et al. The effect of parenteral acepromazine and xylazine on intraocular pressure in the horse. Vet Med Small Anim Clin 1976;71:1727-1730.
19. Trim CM, Colbern GT, Martin CL. Effect of xylazine and ketamine on intraocular pressure in horses. Vet Rec 1985;117:442-443.
20. Wilcock BP, Brooks DE, Latimer CA. Glaucoma in horses. Vet Pathol 1991;28:74-78.
21. Wilkerson M, Cyrlin M, Lippa EA, et al. Four-week safety and efficacy study of dorzolamide, a novel, active carbonic anhydrase inhibitor. Arch Ophthalmol 1993;111:1343-1350.
22. Lippa EA, Schuman JS, Higginbotham EJ, et al. MK-507 versus sezolamide: comparative efficacy of two topically active carbonic anhydrase inhibitors. Ophthalmology 1991;98:308-312.
23. Ridderstrale Y, Wistrand PJ, Brechue WF. Membrane-associated CA activity in the eye of the CA II-deficient mouse. Invest Opthalmol Vis Sci 1994;35:2577-2584.
24. Wistrand PJ, Schenholm M, Lonnerholm G. Carbonic anhydrase isoenzymes CA I and CA II in the human eye. Invest Ophtalmol Vis Sci 1986;27:419-428.
25. Matusi H, Murakami M, Wynns GC, et al. Membrane carbonic anhydrase (IV) and ciliary epithelium carbonic anhydrase activity is present in the basolateral membranes of the non-pigmented ciliary epithelium of rabbit eyes. Exp Eye Res 1996;62:409-417.
26. Baldwin JJ, Ponticello GS, Anderson PS, et al. Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucoma. J Med Chem 1989;32:2510-2513.
27. Wang RE, Serle JB, Podos SM, et al. MK-507 (L-671, 152) a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys. Arch Ophthalmol 1991;109:1297-1299.
28. Surgrue MF, Mallorga P, Schwam H, et al. A comparison of L-671.152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals. Curr Eye Res 1990;9:607-615.
29. Maren TH. Carbonic anhydrase: chemistry, physiology, and inhibition. Physiol Rev 1967;47:595-781.
30. Stein A, Pinke R. The effect of topically administered carbonic anhydrase inhibitors on aqueous humor dynamics in rabbits. Am J Ophthalmol 1983;95:222-228.
31. Maus TL, Larsson LI, McLaren JW, et al. Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans. Arch Ophthalmol 1997;115:43-49.
32. Strahlman ER, Tipping R, Vogel R, et al. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol and betaxolol. Arch Ophthalmol 1995;113:1009-1016.
33. Lippa EA, Carlson LE, Ehinger B, et al. Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor. Arch Ophthalmol 1992;110:495-499.
34. King TC, Gum GG, Gelatt KN. Evaluation of a topically administered carbonic anhydrase inhibitor (MK-927) in normotensive and glaucomatous Beagles. Am J Vet Res 1991;52:2067-2070.
35. Heijl A, Strahlman E, Sverisson T, et al. A comparison of dorzolamide and timolol in patients with pseudoexfoliation and glaucoma or ocular hypertension. Ophthalmology 1997;104:137-142.
36. Gum GG, Larocca RD, Gelatt KN, et al. The effect of topical timolol maleate on intraocular pressure in normal beagles and beagles with inherited glaucoma. Prog Vet Comp Ophthalmol 1991;1:141-149.
37. Wilkie DA, Latimer CA. Effects of topical administration of timolol maleate on intraocular pressure and pupil size in dogs. Am J Vet Res 1991;52:432-435.
38. Wilkie DA, Latimer CA. Effects of topical administration of timolol maleate on intraocular pressure and pupil size in cats. Am J Vet Res 1991;52:436-440.
39. Opremcak EM, Weber PA. Interaction of timolol and caffeine on intraocular pressure. J Ocul Pharmacol Ther 1985;1:227-234.
40. Clineschmidt CM, Williams RD, Snyder E, et al. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Ophthalmology 1999;106(suppl 12):17-24.
41. Hutzelmann J, Owens S, Shedden A, et al. Comparison of the safety and efficacy of the fixed combination of dorzolamide/timolol and the concomitant administration of dorzolamide and timolol: a clinical equivalence study. Br J Ophthalmol 1998;82:1249-1253.